Belgium-based Amakem NV has announced the appointment of Maarten van Geffen as head of CMC and Operations. The kinase platform …

PR firm Fishburn Hedges has been appointed by the Health Foundation to review and refresh the charity’s corporate communications. The …
Boehringer Ingelheim is collaborating with US digital health specialist Healthrageous on a scheme to help type II diabetes sufferers manage …

Janssen has licensed a portfolio of drugs designed to regenerate insulin-producing beta cells. Janssen will receive exclusive access to a …
Swedish biotech company BioInvent has suffered a new blow with the failure of its lead pipeline candidate. The company’s share …
Biopharma development firm Chelsea Therapeutics has announced a major corporate reorganisation. The move includes a significant reduction in headcount, the …

Jan Van Ruymbeke has been appointed as the new chief executive of Daiichi Sankyo Europe from October. Van Ruymbeke, from Belgium, …
Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …

Sanofi has withdrawn its marketing applications worldwide for its drug Mulsevo. Designed to stop blood clots in cancer patients receiving …

Xarelto is to be given a FDA fast-track review for a range of anti-blood clotting uses. Xarelto (rivaroxaban) gained its …

The FDA has asked pharma companies to make sure that glycerin and other ingredients used in their products are not …
Recruitment drive starts at Aesica, Affymax names a new manufacturing head, plus updates from NeoStem, DPT Labs and HAL Allergy.

Swiss contract manufacturing organisation Siegfried has announced plans to build a new manufacturing facility in Nantong, near Shanghai in China. …

Savient Pharmaceuticals has appointed Louis Ferrari to the role of president and chief executive for the firm. Ferrari succeeds Savient’s …
Japanese pharma firm Shionogi & Co has opened a new office in London and pledged to expand into Europe. Osaka-based …
Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows of Harvard College. The aim of the …
I’ve often said that however bad one’s research, it’s possible to get it published somewhere. I have been thinking about …

Sanofi has confirmed that it is considering a restructuring of its operations in France, but has refused to comment on …

Merck’s Erbitux has failed to increase survival in patients with gastric cancer, representing a blow to the firm’s ambition to …

GolinHarris, a division within Interpublic Group, will acquire the medical communications firm Virgo HEALTH. Virgo HEALTH will retain its name …